Showing results (171-180 of 339) with videos related to
Sort By:
Pageof 34
Journal of Clinical Pathology|August 1, 1992
Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcomaJ B Schofield, J Mansi, R S Camplejohn, et al.The Journal of Pathology|September 1, 1992
p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumoursY Soini, K Vähäkangas, K Nuorva, et al.Current Biology : CB|July 19, 2000
Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4ET P Herbert, R Fåhraeus, A Prescott, et al.The EMBO Journal|September 1, 1993
DbpA: a DEAD box protein specifically activated by 23s rRNAF V Fuller-Pace, S M Nicol, A D Reid, et al.Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1992
Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomasY Soini, P Pääkkö, K Nuorva, et al.Oncogene|January 1, 1992
Cellular localization and T antigen binding of the retinoblastoma proteinJ Bártek, B Vojtĕsek, R J Grand, et al.Proceedings of the Royal Society of London. Series B, Biological Sciences|October 22, 1985
Cellular targets for SV40 large T-antigenD P Lane, V Simanis, R Bartsch, et al.Current Biology : CB|January 1, 1996
Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4AR Fåhraeus, J M Paramio, K L Ball, et al.Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1992
Low p53 protein expression in salivary gland tumours compared with lung carcinomasY Soini, D Kamel, K Nuorva, et al.Cell Death and Differentiation|November 3, 2007
R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapyA Dey, E T Wong, C F Cheok, et al.Pageof 34